In the best case scenario, BASF is expected to align with a 2°C pathway by 2030. The company’s pathway to 2030 is now better evidenced, supported by tangible actions in renewable sourcing, efficiency, and pilot-scale low-carbon technologies. However, reliance on post-2030 technological deployment, weak Scope 3.1 targets with incomplete coverage, and modest transition capex commitments mean that BASF is not aligned with a 1.5°C pathway.

Bayer is projected to align with a 2°C warming scenario by 2030. Emissions trends have been inconsistent year-on-year, and key downstream categories, such as product use, remain excluded from Scope 3 disclosures, resulting in a likely underestimation of Bayer’s climate footprint.

Incitec Pivot is on track for a 1.5°C pathway by 2030. While Incitec Pivot demonstrates credible initiatives, such as technological innovation and strategic partnerships, certain transparency gaps remain.

Toray aims for carbon neutrality by 2050 but is most likely heading towards a 2°C to 3°C scenario by 2030. Without stronger absolute reduction commitments, enhanced supply chain accountability, and clearer links between incentives and Net Zero goals, Toray appears unlikely to align with the more ambitious 1.5°C target.

Report from Planet Tracker urges investors to address the financial risks associated with toxic chemicals, which are key drivers of environmental damage, as well as being responsible for chronic and acute impacts on human health.

The release of novel entities — artificial chemicals and other human-made pollutants — into the biosphere, has accelerated to a point that they have exceeded their planetary boundary, threatening the Earth operating system, along with humanity. Planet Tracker’s latest report, ‘Novel Entities – A Financial Time Bomb’, presents a detailed analysis of the risks of one of Earth’s nine boundaries, novel entities. The report highlights their risk to both human and planetary health and warns investors of the significant financial risk they face from not considering their potential impact.

SABIC is expected to be on a 2°C pathway by 2030 according to analysis by Planet Tracker. The company aims for carbon neutrality by 2050, targeting a 20% reduction in Scope 1 and 2 GHG emissions by 2030 from a 2018 baseline. However, Planet Tracker’s analysis shows that SABIC lacks a specific Scope 3 emissions target, which accounts for 70% of its footprint, and therefore the company will miss the alignment with the latest Paris Agreement ambition.

Bayer is projected to align with a 2°C warming scenario by 2030, according to an updated analysis by Planet Tracker. This compares to an earlier 3°C projection in August 2023. The company aims for Net Zero GHG emissions by 2050, with interim goals for 2030, and achieved an 11% reduction in total GHG emissions from 2019 to 2023. However, Planet Tracker’s analysis shows significant variability in emissions trends, suggesting Bayer might struggle to meet its 2030 targets.

Planet Tracker’s report, Tomorrow’s Chemistry, presents a comparative analysis of the Climate Transition Assessments (CTAs) of seven leading chemical companies, Air Liquide (AI), BASF (BAS), Bayer (BAY), Dow (DOW), Incitec Pivot (IPL), LyondellBasell (LYB), and Toray Industries (3402), shedding light on their commitments, strategies and readiness to align with the Paris Agreement and achieve Net Zero emissions by 2050.

BASF has recently upgraded its climate transition plan aligning with some recommendations from Planet Tracker, especially regarding setting (partial) Scope 3 targets. BASF unveiled upgraded targets in December 2023, adding to its mitigation goals to reduce Scope 1 and2, some Scope 3 emissions. Notably, the company plans to decrease specific upstream Scope 3 emissions by 15% by 2030.